Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy

@article{Nakahara2011CurrentCI,
  title={Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy},
  author={Jin Nakahara and Michiko Maeda and S. Aiso and N. Suzuki},
  journal={Clinical Reviews in Allergy & Immunology},
  year={2011},
  volume={42},
  pages={26-34}
}
  • Jin Nakahara, Michiko Maeda, +1 author N. Suzuki
  • Published 2011
  • Medicine
  • Clinical Reviews in Allergy & Immunology
  • Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system that affects millions of patients worldwide. The current disease-modifying therapies (DMTs) that are widely used to treat MS only show modest effects. Because MS is a chronic disease, it is important to develop treatments that have better long-term efficacy. Recently, several new-generation DMTs have been developed, most of which target specific immune molecules based on the assumption that MS is an… CONTINUE READING
    98 Citations

    Figures and Topics from this paper

    Paper Mentions

    Interventional Clinical Trial
    Purpose of study is to determine safety and efficacy of use of autologous Adipose-Derived cellular Stromal Vascular Fraction (AD-cSVF) suspended in Normal Saline and delivered via… Expand
    ConditionsAutoimmune, Multiple Sclerosis
    InterventionDevice, Procedure
    Proteomics of a conundrum: Thoughts on addressing the aetiology versus progression of multiple sclerosis
    • 7
    Corrigendum to ‘Multiple sclerosis: New insights and trends’
    • 2
    • PDF
    The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis
    • 27
    Epigenetics of multiple sclerosis
    • 9
    • Highly Influenced
    • PDF
    Multiple sclerosis and pregnancy- treatment considerations
    • PDF
    Immunogenicity of biopharmaceuticals in chronic inflammatory diseases

    References

    SHOWING 1-10 OF 71 REFERENCES
    Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
    • 2,898
    • PDF
    Rituximab add-on therapy for breakthrough relapsing multiple sclerosis
    • 167
    Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis
    • 234
    • PDF
    Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.
    • 994
    • PDF
    How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis
    • 460
    • PDF
    TNF neutralization in MS
    • 359
    • PDF
    PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS
    • 1,396
    Randomized multicenter trial of natalizumab in acute MS relapses: Clinical and MRI effects
    • 68